C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
10/2006
10/31/2006	US7129225 Administering an effective amount of a protein tyrosine kinase inhibitor (containing first and second module) to the patient to protect against or to treat hearing loss
10/31/2006	US7129214 Therapy for drug resistant bacteria
10/31/2006	CA2276455C Phthalazinones
10/31/2006	CA2191759C Formylaminophenylsulfonylureas, preparation processes and use as herbicides and plant growth regulators
10/31/2006	CA2186508C Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors
10/26/2006	WO2006113864A2 Oxindole compounds and their uses as therapeutic agents
10/26/2006	WO2006113769A1 Vanilloid receptor ligands and their use in treatments
10/26/2006	WO2006113704A2 Subtituted heteroaryl cb1 antagonists
10/26/2006	WO2006112772A1 Combination product
10/26/2006	WO2006112479A1 Nitrogen-containing heterocyclic compound
10/26/2006	WO2006112313A1 Protective agent for retinal neuronal cell comprising indazole derivative as active ingredient
10/26/2006	WO2006111856A1 Pyrazole derivatives as progesterone receptor antagonists
10/26/2006	WO2006111662A2 4h-1,2,4-triazin-5-one derivatives, their preparation and their use as alpha 7 nicotinic acetylcholine receptors
10/26/2006	WO2006111371A1 Pharmaceutically active diazepanes
10/26/2006	WO2006074057A3 Pyrimidine derivatives as kinase modulators and method of use
10/26/2006	WO2006052936A3 Compounds and compositions as protein kinase inhibitors
10/26/2006	WO2005095384A8 Pyrazine derivatives and pharmaceutical use thereof as adenosine antagonists
10/26/2006	US20060241305 Amorphous form of losartan potassium
10/26/2006	US20060241304 Reaction of a 2-carboxypyrrole or 3-carboxy-2H-pyrazole with a sulfonyl chloride and further condensation with an isatoic anhydride in the presence of a tertiary amine to form the 2-(pyrrol-2-yl or pyrazol-3-yl)benzo[1,3]oxazin-4-one; intermediates for crop protection agents and pharmaceuticals
10/26/2006	US20060241302 Morpholine derivatives
10/26/2006	US20060241296 Vanilloid receptor ligands and their use in treatments
10/26/2006	US20060241295 Preparation of pharmaceutical salts of piperazine compounds
10/26/2006	US20060241259 for photopolymerization; photography, relief imaging; color filters
10/26/2006	US20060241161 Process for preparing losartan potassium with improved flowability
10/26/2006	US20060241149 Chemical compounds
10/26/2006	US20060241146 2-cyano-1-[t-4-(4-acetyl-1-piperazinyl)-1-methyl-r-1-cyclohexylamino]acetylpyrrolidine; dipeptidylpeptidase IV (DPPIV) inhibitor; antidiabetic, insulin resistance, hyperglycemia, obesity; antiproliferative agent for T-cell, HIV, AIDS; arthritis, osteoporosis
10/26/2006	US20060241145 Piperidine derivative crystal, process for producing the same, and use
10/26/2006	US20060241140 Imidazolamino compounds
10/26/2006	US20060241137 Triazole compounds and the therapeutic use thereof
10/26/2006	US20060241127 N-[2-Amino-6-(4-pyridinyl)-4-pyrimidinyl]-N-[2-fluoro-4-(1H-pyrrolo[2,3-b]-pyridin-4-yloxy)phenyl]amine, used for the treatment and/or prophylaxis of cardiovascular diseases and erectile dysfunction
10/26/2006	US20060241126 Phospholipase inhibitors perticularly phospholipase A2 enzyme Lipoprotein Associated Phospholipase A2; N-(1-Methylpiperidin-4-yl)-(2-(2-(2,3-difluorophenyl)ethyl)-4-oxo-4H-pyrido[2,3-d]pyrimidin-1-yl)-N-(4-(4-trifluoromethylphenyl)phenyl)methylacetamide; amidation
10/26/2006	US20060241125 Compounds useful in therapy
10/26/2006	US20060241121 Substituted piperazines as CB1 antagonists
10/26/2006	US20060241118 Hydroxamate sulfonamides as cd23 shedding inhibitors
10/26/2006	US20060241117 Therapeutic agents useful for treating pain
10/26/2006	US20060241115 2,3-Dihydro-4H-1,4-benzoxazine derivatives containing an optionally fused pyridine or pyrimidine ring; 7-((6,7-bis(methyloxy)-4-quinolinyl)oxy)-N-phenyl-2,3-dihydro-4H-1,4-benzoxazine-4-carboxamide; kinase inhibitors; inflammation, angiogenesis and cancer
10/26/2006	US20060241114 Derivatives of azasugars as anticancer agents
10/26/2006	US20060241112 Kinase inhibitors
10/26/2006	US20060241111 inhibitors of coagulation factor Xa such as 1-(5-chlorothien-2-ylcarbonyl)-4-[4-(3-oxomorpholin-4-yl)phenyl]-2-propylsemicarbazide, used for preventing thrombosis, infarction, arteriosclerosis, inflammation, bleeding, angina pectoris, restenosis, intermittent claudication and treatment of tumors
10/26/2006	US20060241110 2-(Imidazol-1-ylalkyl)-3H-quinazolin-4-one derivatives; mitotic kinesin KSP inhibitors; anticarcinogenic, antiinflammatory, and antiproliferative agents
10/26/2006	US20060241109 PGD2 receptor antagonists for the treatment of inflammatory diseases
10/26/2006	US20060241105 To control arthropods (including insects and arachnids) and helminths (including nematodes) also valuable to protect timber from sawflies, beetles or termites or use in veterinary medicine; 1-(2,6-Dichloro-4-trifluoromethylphenyl)-3-(N-benzyloxy-2-amidino)-5-methylamino-4-trifluoromethylsulfonylpyrazole
10/26/2006	US20060241101 Novel benzimidazole derivatives and pharmaceutical compositions comprising these compounds
10/26/2006	US20060240048 Pyridine derivatives as cb2 receptor modulators
10/26/2006	US20060239999 Preventive and/or therapeutic drugs for asthma
10/26/2006	US20060239922 Water-soluble fluoro-substituted cyanine dyes as reactive fluorescence labelling reagents
10/26/2006	DE102005017116A1 Hemmstoffe für Inhibitoren von Apoptose Proteinen (IAP) Inhibitors of inhibitors of apoptosis proteins (IAP)
10/26/2006	CA2643677A1 Compositions of novel opioid compounds and method of use thereof
10/26/2006	CA2610446A1 Nitrogen-containing heterocyclic compound
10/26/2006	CA2606288A1 Subtituted heteroaryl cb1 antagonists
10/26/2006	CA2605059A1 Oxindole compounds and their uses as therapeutic agents
10/26/2006	CA2604956A1 Protective agent for retinal neuronal cell comprising indazole derivative as active ingredient
10/26/2006	CA2604942A1 2-amino-quinaz0lin-5-ones
10/26/2006	CA2604920A1 Novel compounds useful for bradykinin b1 receptor antagonism
10/26/2006	CA2604218A1 Pyrazole derivatives as progesterone receptor antagonists
10/26/2006	CA2601979A1 2,3 substituted pyrazine sulfonamides
10/26/2006	CA2600774A1 Pharmaceutically active diazepanes
10/25/2006	EP1713795A2 Candesartan cilexetil polymorphs
10/25/2006	EP1713794A2 Heterocycle grafted monomers and related polymers and hybrid inorganic-organic polymer membranes
10/25/2006	EP1713793A2 Pyrimidinone compounds useful as kinase inhibitors
10/25/2006	EP1713790A2 Method of preparation of benzofuran-2-carboxylic acid (s)-3-methyl-1- ((4s, 7r)-7methyl-3-oxo-1-(pyridine-2-sulfonyl)-az epan-4-ylcarbamoyl-butyl)-amide
10/25/2006	EP1713781A1 Quinazoline derivatives
10/25/2006	EP1713780A2 Novel inhibitors of glutaminyl cyclase
10/25/2006	EP1713778A1 Benzazepine derivatives as histamine h3 antagonists
10/25/2006	EP1713484A2 Compounds and methods of use
10/25/2006	EP1554272B1 Benzimidazoles and benzothiazoles as inhibitors of map kinase
10/25/2006	EP1265606B1 Cell adhesion inhibitors
10/25/2006	CN1852908A Process for the preparation of tetrazole derivatives from organo boron and organo aluminium azides
10/25/2006	CN1852906A Novel compounds
10/25/2006	CN1852905A N-substituted benzimidazolyl c-kit inhibitors
10/25/2006	CN1852900A 2,4-di (phenylamino) pyrimidines useful in the treatment of proliferative disorders
10/25/2006	CN1852714A Quinazoline analogs as receptor tyrosine kinase inhibitors
10/25/2006	CN1852710A Pyrazolines as PAR-1 antagonists for treatment of cardiovascular diseases
10/25/2006	CN1281605C Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands
10/25/2006	CN1281585C Cyclic diamine compounds having fused-ring groups
10/24/2006	US7126010 Benzylcycloalkyl amines as modulators of chemokine receptor activity
10/24/2006	US7126007 Reproducible; avoids use of 3-pyrrolidinol as a starting material
10/24/2006	US7126006 Substituted amine radical as building blocks; increases structural diversity
10/24/2006	US7125995 Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (PARS)
10/24/2006	US7125993 A2B adenosine receptor antagonists
10/24/2006	US7125990 For treatment of depression, anxiety, affective disorders, feeding disorders, post-traumatic stress disorder, headache, drug addiction, inflammatory disorders, drug or alcohol withdrawal symptoms
10/24/2006	US7125989 Hetero diels-alder adducts of pentacene as soluble precursors of pentacene
10/24/2006	US7125905 Pyrrole substituted 2-indolinone protein kinase inhibitors
10/24/2006	US7125891 Such as (1-((2,3-dihydro-2-(4-propyl-1H-imidazol-2-yl)-1H-indol-1 -yl)carbonyl)propyl)-carbamate; for inactivation of cholecystokinins
10/24/2006	US7125887 Pyrrolidine modulators of CCR5 chemokine receptor activity
10/24/2006	US7125886 2-imidazomethyl- pyrido(4,3-b)indol-1-one or -carbazol-1-one derivatives containing an ester group; especially for treating irritable bowel syndrome.
10/24/2006	US7125883 alpha v beta 3 integrin receptor modulators; treating variety of diseases including cardiovascular disorders, retinopathy, strokes, cancer, osteoporosis, tumor metastasis, high blood pressure, psoriasis, antiviral, antimycotic, antiparasitic or antibacterial therapy; 1,2-dihydropyrimidin-2-one moiety
10/24/2006	US7125881 Use of pyrimidine—or triazine—2 carbonitiles for treating diseases associated with cysteine prostease activity and novel pyrimidine-2-carbonitile derivatives
10/24/2006	US7125879 Prevention reproduction of virus
10/24/2006	US7125878 For therapy and prophylaxis of cardiovascular diseases, diabetes, diabetes- associated disorders, inflammatory diseases, immunological disorders, dermatological disorders, oncological disorders and central nervous system disorders
10/24/2006	US7125877 Brain disorders; psychological disorders; central nervous system disorders; antidiabetic agents; hypotensive agents
10/24/2006	US7125866 Therapeutic applications of pro-apoptotic benzodiazepines
10/24/2006	US7125863 Inhibitors of dipeptidyl peptidase IV
10/24/2006	CA2261848C Cell adhesion inhibitors
10/24/2006	CA2252952C Substituted aminomethylphenylsulphonylureas, their preparation, and their use as herbicides and plant growth regulators
10/24/2006	CA2246678C Substituted 2-aryl-1,2,4-triazine-3,5-di(thi)ones as herbicides
10/24/2006	CA2223094C Phenylpyridazinones
10/24/2006	CA2214752C Herbicidal or fungicidal sulphonylaminocarbonyltriazolinones with halogenated alk(en)oxy substituents
10/24/2006	CA2211411C Sulphonyl amino(thio)carbonyl-1,2,4-triazolin(thi)one derivatives, the production thereof and the use thereof as herbicides
10/24/2006	CA2168023C Vasoconstrictive substituted aryloxyalkyl diamines

1 ... 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 ... 626